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The following multiple-choice questions test your knowledge
on smoking (cessation), exercise, and obesity/heart
healthy food. Only one answer is correct (see below plus
appropriate literature references). Good luck!
Smoking and smoking cessation
(1) What is the percentage of all avoidable deaths that
smoking is responsible for in long-term smokers?
(a) 20% (one half of these because of cardiovascular
disease),
(b) 35% (one half of these because of cardiovascular
disease),
(c) 50% (one half of these because of cardiovascular
disease),
(d) 75% (one half of these because of cardiovascular
disease).
(2) How many of your patients – on average – will stop
smoking after an acute coronary syndrome of coronary
artery bypass grafting?
(a) ± 30%,
(b) ±50%,
(c) ±70%,
(d) ±90%.
(3) How long does it take in patients with coronary artery
disease who stop smoking before their risk falls to the
level of those patients with coronary artery disease
who never smoked?
(a) 1–6 months,
(b) 1–2 years,
(c) 2–3 years,
(d) 5–10 years.
(4) What is the effect of a smoking ban in public places
on acute coronary syndromes in nonsmokers?
(a) No effect,
(b) ±5% reduction,
(c) ± 10% reduction,
(d) ±20% reduction.
Exercise and the heart
(1) What is the current public health recommendation
(European Society of Cardiology) for physical
activity?
(a) 15–20min of moderate intensity activity on 2–3 days
of the week,
(b) 30–45min of moderate intensity activity on 2–3 days
of the week,
(c) 15–20min of moderate intensity activity on most
days of the week,
(d) 30–45min of moderate intensity activity on most
days of the week.
(2) How would you make a prescription for moderate
intensity activity after having performed an exercise
stress test?
(a) Preferred target heart rate during peak exercise of
50–60% of average maximum heart rate,
(b) Preferred target heart rate during peak exercise of
60–75% of average maximum heart rate,
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(c) Preferred target heart rate during peak exercise of
75–85% of average maximum heart rate,
(d) Preferred target heart rate during peak exercise of at
least 85% of average maximum heart rate.
(3) What is the minimum cardiorespiratory-fitness
level that is associated with significantly lower
cardiovascular event rates for a man at 50 years
of age? (expressed in metabolic equivalent units,
1 MET corresponding to 3.5ml/min/kg of oxygen
consumption).
(a) 6 MET,
(b) 7 MET,
(c) 8 MET,
(d) 9 MET.
(4) What is the minimum cardiorespiratory-fitness level
that is associated with significantly lower
cardiovascular event rates for a woman at 50 years
of age? (expressed in metabolic equivalent units,
1 MET corresponding to 3.5ml/min/kg of oxygen
consumption).
(a) 6 MET,
(b) 7 MET,
(c) 8 MET,
(d) 9 MET.
(5) How many of your patients – on average – will take
up some physical activity outside work (20min Z 3
times a week) after an acute coronary syndrome of
coronary artery bypass grafting?
(a) ± 15%,
(b) ±25%,
(c) ±50%,
(d) ±75%.
Obesity and heart healthy food
(1) What is the prevalence of obesity (body mass index
30 kg/m2) – on average – in your patients after an
acute coronary syndrome of coronary artery bypass
grafting?
(a) ± 15%,
(b) ±25%,
(c) ±35%,
(d) ±50%.
(2) Which is the most effective weight-loss diet?
(a) High-fat diet,
(b) High-protein diet,
(c) Low-carbohydrate diet,
(d) Reduced-calorie diets result in similar weight loss,
regardless of their macronutrient composition.
(3) What is incorrect regarding trans fatty acids?
(a) They can be monounsaturated or polyunsaturated
fatty acid isomers,
(b) They are mainly derived from meats, dairy products,
margarines and ready-cooked meals from the food-
processing industry,
(c) They are associated with lower LDL-cholesterol levels
and lower cardiovascular morbidity and mortality,
(d) They are associated with higher LDL-cholesterol
levels and higher cardiovascular morbidity and
mortality.
(4) What is not correct regarding the Mediterranean
diet?
(a) It is characterized by a high intake of monounsaturated
fat, plant proteins, whole grains, and fish; moderate
intake of alcohol; and low consumption of red meat,
refined grains, and sweets,
(b) A stricter adherence to the Mediterranean diet is
inversely associated with total and cardiovascular
mortality,
(c) It is less effective than a low-fat diet in the secondary
prevention of cardiac events,
(d) A stricter adherence to the Mediterranean diet is
inversely associated with the risk of stroke in women.
Answers
Smoking and smoking cessation
(1) Answer (c). European Guidelines on Cardiovascular
Disease Prevention. Fourth Joint European Societies’
Task Force on cardiovascular disease prevention
in clinical practice. Eur J Cardiovasc Prev and Rehabil
2007; 14 (suppl 2):S1–S113. p. S23.
(2) Answer (b). Kotseva K, Wood D, De Backer G,
De Bacquer D, Pyorala K, Keil U, et al., on behalf of
the EUROASPIRE Study group. EUROASPIRE III:
a survey on the lifestyle, risk factors and use of
cardioprotective drug therapies in coronary patients
from 22 European countries. Eur J Cardiovasc Prev
Rehabil 2009; 16:121–137.
(3) Answer (c). European Guidelines on Cardiovascular
Disease Prevention. Fourth Joint European Societies’
Task Force on cardiovascular disease prevention in
clinical practice. Eur J Cardiovasc Prev and Rehabil
2007; 14 (Suppl 2):S1–S113. p. S23.
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(4) Answer (d). Pell JP, Haw S, Cobbe S, NEwby DE,
Pell AC, Fisehbacher C, et al., Smoke-free Legislation
and Hospitalizations for Acute Coronary Syndrome.
New Engl J Med 2008; 359:482–491.
Exercise and the heart
(1) Answer (d). European Guidelines on Cardiovascular
Disease Prevention. Fourth Joint European Societies’
Task Force on cardiovascular disease prevention in
clinical practice. Eur J Cardiovasc Prev and Rehabil
2007;14(suppl 2):S1–S113. p. S40.
(2) Answer (b). European Guidelines on Cardiovascular
Disease Prevention. Fourth Joint European Societies’
Task Force on cardiovascular disease prevention in
clinical practice. Eur J Cardiovasc Prev and Rehabil
2007;14(suppl 2):S1–S113. p. S40.
(3) Answer (c). Kodama S, Saito K, Tanaka S, maki M,
Yachi Y, Asumi M, et al. Cardiorespiratory fitness as
a quantitative predictor of all-cause mortality
and cardiovascular events in healthy men and
women. JAMA 2009; 301:2024–2035. (meta-analysis
of 33 trials comprising more than 187 000 healthy
men and women).
(4) Answer (a). Kodama S, Saito K, Tanaka S, Maki M,
Yachi Y, Asumi M, et al. Cardiorespiratory fitness as a
quantitative predictor of all-cause mortality and
cardiovascular events in healthy men and women.
JAMA 2009; 301:2024–2035. (meta-analysis of 33
trials comprising more than 187 000 healthy men and
women).
(5) Answer (a). Kotseva K, Wood D, De Backer G,
De Bacquer D, Pyorala K, Keil U, et al. on behalf of
the EUROASPIRE Study group. EUROASPIRE III:
a survey on the lifestyle, risk factors and use of
cardioprotective drug therapies in coronary patients
from 22 European countries. Eur J Cardiovasc Prev
Rehabil 2009; 16:121–137.
Obesity and heart healthy food
(1) Answer (c). Kotseva K, Wood D, De Backer G, De
Bacquer D, Pyorala K, Keil U, on behalf of the
EUROASPIRE Study group. EUROASPIRE III:
a survey on the lifestyle, risk factors and use of
cardioprotective drug therapies in coronary patients
from 22 European countries. Eur J Cardiovasc Prev
Rehabil 2009; 16:121–137.
(2) Answer (d). Sacks FM, Bray GA, Carey VJ, Smith SR,
Ryan DH, Anton SD, et al. Comparison of weight-loss
diets with different compositions of fat, protein, and
carbohydrates. N Engl J Med 2009; 360:859–873.
(3) Answer (c). European Guidelines on Cardiovascular
Disease Prevention. Fourth Joint European Societies’
Task Force on cardiovascular disease prevention in
clinical practice. Eur J Cardiovasc Prev and Rehabil 2007;
14 (suppl 2):S1–S113. p. S27.
(4) Answer (c). De Lorgeril M, Salen P, Martin JL,
Mohjaud I, Delaye J, Mamelle N. Mediterr-
anean diet, traditional risk factors and the rate of
cardiovascular complications after myocardial
infarction: final report of the Lyon Diet Heart
Study. Circulation 1999; 99:779–785 and Fung T,
Rexrode KM, Mantzoros CS, Manson JE, Willets WC,
Hu FB. Mediterranean diet and incidence of and
mortality from coronary heart disease and stroke in
women. Circulation 2009; 119:1093–1100.
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